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 Abstract 
Identification of a critical gene in the dihydroergot alkaloid pathway 
Yulia Bilovol 
Ergot alkaloids, bioactive compounds produced by some species of fungi, have had significant 
impacts on agriculture and medicine. Claviceps purpurea and Epichloë spp. are ergot alkaloid 
producers associated with agricultural commodities and negatively affect humans and grazing 
animals, respectively. Another ergot alkaloid-producing fungus called Aspergillus fumigatus is 
ubiquitous in the environment; infections arising after inhaling the spores may kill 
immunocompromised persons. Ergot alkaloids and their derivatives are utilized by the 
pharmaceutical industry for the development of drugs. Some of these drugs are derived from 
lysergic acid, whereas others are derived from dihydrolysergic acid. Lysergic acid derivatives 
have vasoconstrictive properties and are used as treatment of acute headaches and in obstetrics. 
Dihydrolysergic acid derivatives are vasorelaxant and are the basis of drugs that help treat 
dementia, Alzheimer’s, and Cushing’s diseases. The ergot alkaloid pathway has largely been 
elucidated, but unknown steps remain, particularly in the dihydrolysergic acid branch. The gene 
encoding the enzyme that oxidizes festuclavine, a key intermediate in the dihydrolysergic acid 
branch, to fumigaclavine B is unknown. Based on DNA sequence analysis, we hypothesized that 
the A. fumigatus gene easM encodes this enzyme. To test this hypothesis we knocked out easM 
by inserting a hygromycin resistance gene in the middle of its coding sequence and transforming 
A. fumigatus with this construct. HPLC analysis showed that knock out of easM blocked the 
ergot pathway at festuclavine, and three downstream products (fumigaclavines B, A, and C) were 
eliminated. PCR results showed the hygromycin resistance fragment was present in the middle of 
easM-coding sequences in these transformants. Complementation, or reintroduction of the native 
non-disrupted easM gene restored the ability of the fungus to produce all downstream 
compounds. These results indicate that easM encodes the enzyme that oxidizes festuclavine to 
fumigaclavine B. The festuclavine-accumulating strain of A. fumigatus will be instrumental in 
future studies investigating the biosynthesis of dihydrolysergic acid derivatives, which are 
derived from festuclavine and are the basis for important vasorelaxant drugs.
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1 Overview 
Ergot alkaloids are bioactive compounds that can be produced by several different 
species of fungi in the families Clavicipitaceae and Trichocomaceae. These fungi, collectively, 
can be found in a variety of environments. Some can live as saprotrophs, whereas others can 
infect a variety of hosts, including grasses and cereals, or humans and animals. The ergot 
alkaloid pathway for all ergot alkaloid-producing fungi appears to be shared in the early steps, 
but their divergence at the chanoclavine-I aldehyde branch point (Figure 1) leads to unique end 
products that are dependent upon the species of fungus producing them (Panaccione et al. 2012). 
Typical products of these pathways include clavines and lysergic acid derivatives. The 
synthesized chemicals are pertinent in medicine, as they are used in pharmaceuticals, and are of 
concern in agriculture due to their effect on grazing animals. Ergot alkaloid biosynthesis has 
been well studied but a few unknown steps remain thus, further understanding of these 
compounds can be of benefit for applications in medicine and agriculture in the future.  
 
1.1 History and significance 
Ergot alkaloid-producing fungi established their significance throughout history. 
Agricultural notoriety took root when grain crops, particularly rye, infected with Claviceps 
purpurea caused products made from the infected cereals to be unsafe to eat. A hard black 
structure called a sclerotium replaces seed within the flowering portion of the grass and was 
processed as grain until its deleterious effects were discovered. The mycotoxins produced within 
these hard overwintering structures are able to survive baking temperatures and digestive 
conditions, thus making them tenacious toxins (Merkel et al. 2012). Ergot poisoning or ergotism 
causes a variety of symptoms from hallucinations to gangrene of the extremities and convulsions 
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(Belser-­‐Ehrlich et al. 2013). “St. Anthony’s fire” or ignis sacer derives its name from the burning 
sensations occurring in the extremities due to the vasoconstrictive activities of ergot alkaloids 
ingested from ergot-infected grains. Ergotism left such an impression on history that renaissance 
painters like Matthias Grünewald and Hieronymus Bosch immortalized the disease through art. 
Fortunately, the diversification of diets and processing or screening of grain has largely 
alleviated ergotism’s threat to consumers. Belser-Ehrlich et al. (2013) chronicle the major 
outbreaks of ergotism in humans since 1900 occurring in Russia in 1926-1927, England in 1927, 
Ireland in 1929, France in 1951, India in 1956-1957 and 1975, and Ethiopia in 1977-1978 and 
2001. Luckily these outbreaks have not been equal in magnitude to those of the Middle Ages, 
and they were confined to remote areas or countries where regulations are not rigorous. Current 
regulations in developed countries around the world limit the amount of ergot that can be 
consumed by humans; for example, in the US the limit for ergot presence in rye cannot exceed 
0.3 percent (Code of Federal Regulations 2001) and is lower for other products like oats, wheat, 
and barley. 
Deleterious effects from ergot-producing fungi may also be experienced by livestock 
ingesting contaminated grasses or feed. Epichloë species, grass symbionts capable of producing 
ergot alkaloids, have been known to cause grazing livestock to experience unfavorable 
symptoms including vasoconstriction at the extremities resulting in gangrene (Schardl et al. 
2006). Epichloë endophytes are known to produce four classes of alkaloids: ergot alkaloids 
(lysergic acid and ergovaline), indolediterpenes, pyrrolopyrazine, and aminopyrrolizidines that 
act as insecticidal compounds. Among these four classes, ergot alkaloids and indolediterpenes 
can affect vertebrates (Schardl and Phillips 1997). Coupled with environmental conditions, ergot 
toxicosis has varying effects on livestock. For example in heat stress conditions, animals that 
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ingest the toxins lose control of body temperature, water balance, experience necrosis of adipose 
tissue, and have the tendency to eat less food. Ingestion of toxins in cold conditions leads to 
gangrene. In general, toxin ingestion causes a reduction of lactation and fertility and, particularly 
in horses, miscarriages, fetal abnormalities, and stillbirths (Schardl and Phillips 1997). Economic 
losses due to livestock toxicosis may be ameliorated by using genetic techniques targeting toxin 
producing genes of mycobionts. Genetic engineering techniques are being explored, but since 
endophytes benefit their plant hosts, special attention needs to be paid to the acuteness of 
toxicosis in animals and environmental and genetic factors in selecting agronomically desirable 
endophytes that will maintain their endophyte niche but will not harm grazing livestock. Thus, 
there is still much to be explored regarding the control of toxin producing endophytes.  
Ergot alkaloids’ effects on history were not all negative; people have attempted to 
harness their biological activities for religious ceremonies and medicinal applications. In ancient 
Aztec cultures, priests would eat morning glory seeds with their associated alkaloid producing 
endophytes to induce psychoactive effects as a means of communication with the gods 
(Hofmann, Rätsch, & Schultes 1992). Albert Hoffman was the research chemist responsible for 
the discovery of lysergic acid diethylamide (LSD) and also investigated the psychoactive effects 
of seed endophytes and hallucinogenic mushrooms eaten in South America (Hoffman 1980). His 
studies indicated that the chemicals lysergic acid amide, ergonovine, and lysergic acid 
hydroxyethylamide (the main active component in the preparations ingested by the indigenous 
people of South America) are closely chemically related to LSD. Beyond the psychoactive 
effects, lysergic acid derivatives act on smooth muscle tissues which is why midwives in the 
Middle Ages utilized ergot alkaloids to aid in child birth; however, because concentrations of 
alkaloid were difficult to control in preparations and often caused complications they eventually 
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fell out of use (Tudzynski, Correia, & Keller 2001). With time, more became known about 
alkaloid activities and with it the ability to control dosage. Alkaloids began being incorporated 
into headache medications and a host of other drugs on the market today. 
 
1.2 Ergot alkaloid-producing organisms  
Aspergillus fumigatus is a common saprophyte in the phylum Ascomycota. A. fumigatus 
plays a role in an agricultural aspect: it spoils stored crops, such as animal feed especially in 
warm, moist conditions (Scudamore & Livesey 1997). A. fumigatus is ubiquitous due to its key 
role in environmental decay; thus, it can be found at especially high concentrations around 
composting facilities and other areas where there is a large amount of decomposing matter. A. 
fumigatus conidia are minute and very buoyant (Panaccione and Coyle 2005) allowing them to 
travel great distances, aiding the organism in spread and infection. The presence of A. fumigatus 
in air has been associated with respiratory ailments and allergic symptoms in humans. In 
immunocompromised persons it may manifest as invasive aspergillosis or systemic spread of 
infection, with a mortality rate of more than fifty percent. In healthy individuals, the immune 
system will typically clear the infection, but in some cases the fungus may colonize cavities 
within lung tissue or sinuses resulting in aspergilloma or fungus ball (Denning 1998).  
A. fumigatus synthesizes alkaloids called clavines, or more particularly festuclavine, 
fumigaclavine A, fumigaclavine B, and fumigaclavine C, with fumigaclavine A or fumigaclavine 
C typically occurring as the end product in the pathway (Robinson and Panaccione 2012). 
Alkaloid production is associated with asexual reproduction, with alkaloid metabolites localized 
in the conidia (Coyle et al. 2007). Aspergillus fumigatus is an ideal candidate for the study of 
ergot alkaloid biosynthesis because it grows quickly in the saprophytic state in vitro yielding 
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measureable amounts of chemical. Its genome has also been sequenced, with numerous studies 
investigating genes within the ergot alkaloid gene cluster through knockout and 
complementation studies. Resulting knockout strains are important for serving as recipients for 
the expression of ergot alkaloid synthesizing genes of other fungi. This study follows suit with 
the knockout and complementation of a gene with an unassigned role in the ergot alkaloid gene 
cluster. Future studies will be able to utilize the knockout strain of A. fumigatus as a recipient for 
a gene of interest in an attempt to understand dihydroergot alkaloid biosynthesis.  
Epichloë spp. (formally Neotyphodium spp.) are another genus of fungi in the family 
Clavicipitaceae that produce ergot alkaloids; they are grass symbionts that colonize above 
ground portions of plants, growing in the intercellular spaces. Tall fescue and perennial rye grass 
are two of the most commonly studied grasses relating to Epichloë spp. as symbionts. Symbiotic 
or endophytic relationships between grasses and Epichloë species are seed transmissible (Bacon 
& White 2000) meaning that the symbiotic fungus not only grows in the intercellular spaces of 
the plant but that it will grow into the developing seed for the purpose of dispersal and 
colonization when the new seed germinates. The mutualism provides the plant with drought 
tolerance, enhanced photosynthetic rate, and growth (Clay & Schardl 2002). Ergot alkaloid 
production in plants has also been shown to deter herbivory; a study found that rabbits preferred 
to eat grasses colonized by endophytic fungi that were alkaloid free versus grasses containing 
alkaloids or even endophyte-free grasses (Panaccione et al. 2006). Additionally, it has been well 
documented that biologically active alkaloids of the fungus have insecticidal activities, 
conferring protection to its host and increasing its competitiveness (Schardl et al. 2004). The 
lysergic acid derivatives produced by Epichloë spp. cause livestock feeding on these grasses to 
experience detrimental effects such as poor fertility, convulsions, poor weight gain, gangrene, 
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and even death (Schardl & Phillips 1997). Studying alkaloid producing endophytes is worthwhile 
to understand how they can be better managed out in the field to decrease their effects on the 
economic loses pertaining to grazing animals. 
 
1.3 Ergot alkaloid cluster, pathway, and unknown steps  
 Ergot alkaloid synthesizing genes are found in clusters; however, the clusters vary 
depending on the organism (Figure 2). Genetic variation within clusters between species allows 
for the rich diversity in the ergot alkaloid pathway allowing some species to produce lysergic 
acid derivatives, dihydrolysergic acid derivatives, ergopeptines, or fumigaclavines (Figures 1 & 
3). Arrangement of genes, variation in coding sequences for alleles, and even the presence or 
absence of some genes within clusters vary, and may be observed via sequencing of the ergot 
alkaloid clusters (Figure 2) (Schardl et al. 2013; Coyle and Panaccione 2005). For example, 
genes unique to the A. fumigatus cluster (easN, and easL,) are responsible for the production of 
different fumigaclavines (Figure 4). All of these genes have been sequenced, but some of their 
roles have not yet been assigned; this is the primary focus of this study. 
Early steps in the ergot alkaloid synthesis pathway are evolutionarily conserved among 
alkaloid producing fungi (Figure 3). An early step in the ergot alkaloid pathway is the 
prenylation of tryptophan by DMATrp synthase, coded by the dmaW gene. Genetic and 
biochemical analyses demonstrated that it is the determining step in the ergot pathway for A. 
fumigatus (Coyle and Panaccione 2005). Knockout of dmaW in A. fumigatus completely 
eliminated all ergot alkaloids from the mutant, and the complementation restored production. 
The next important feature of the pathway is the chanoclavine-I aldehyde intermediate, at which 
the pathway diverges and varying terminal branch products are made according to individual 
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producers (Panaccione et al. 2012). Understanding which genes are responsible for each step in 
these pathways is critical for the study of the biosynthesis of the biologically important end 
products. Investigation of one of the remaining unknown steps, for which easM is hypothetically 
responsible, will help complete the pathway for the production of fumigaclavines in A. fumigatus 
and will be instrumental for future research of dihydroergot alkaloid biosynthesis.  
 
1.4 Justification for choosing easM as a target gene  
 One of the few remaining unknown steps in fumigaclavine synthesis for A. fumigatus is 
the oxidative step responsible for modifying festuclavine into fumigaclavine B. Two candidate 
genes for this step are easM and easK, which are located in the ergot alkaloid gene cluster 
(Figures 2 & 4) and for which roles have not yet been assigned. Two pieces of evidence used to 
choose easM as the candidate gene for this study were as follows. First, the proposed structure 
for the protein coded by easM indicates that it is a P450 monooxygenase (Panaccione 2010). 
This putative function aligns well with the activity required to convert festuclavine to 
fumigaclavine B, which differs only by the presence of a hydroxyl group. Second, comparative 
genomics of A. fumigatus with Penicillium commune, organisms with similar clusters and similar 
ergot alkaloid profiles, indicates that the presence of easM and not easK correlates with the 
ability to produce ergot alkaloids (Panaccione 2010; Coyle & Panaccione 2005; Wallwey and Li 
2011). Both easM and easK are present in A. fumigatus but P. commune only has easM while 
still retaining the ability to produce alkaloids (Wallwey and Li 2011). This leads us to 
hypothesize that easK is not essential for alkaloid production or that it may be redundant with 
easM. Both of these clues suggest that easM is the responsible gene for festuclavine oxidation to 
fumigaclavine B.  
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1.5 Benefits of research – agricultural and pharmaceutical implications  
Pharmaceutically, derivatives of the ergot alkaloid pathway are important because they 
can be incorporated into drugs. Ergot alkaloids are similar in molecular structure to 
neurotransmitters that interact with serotonin, dopamine, adrenaline, and neurodreneline 
receptors (Belser-­‐Ehrlich et al. 2013; Panaccione 2011). These similarities are attributed to the 
psychoactive and/or vasoconstrictive or relaxant properties associated with these mycotoxins. 
Mycotoxin agonism for serotonin-2A receptors is thought to be responsible for the 
hallucinogenic properties of ergot alkaloids (Vollenweider et al. 1998). Vasoconstrictive 
symptoms in the extremities are linked to alkaloids interacting with serotonin-1B/D receptors 
(Anderson et al. 1987). Vasoconstrictive properties of lysergic acid derivatives have been used to 
induce labor, terminate postpartum bleeding, and mimic dopamine (Hoffman 1980). Lysergic 
acid derivatives are currently ingredients in drugs that treat type II diabetes (Via et. al. 2010) and 
act as neurotransmitter agonists (Cabergoline) for treatment of pituitary disorders like 
Parkinson’s disease. It is important to note that because alkaloids have affinities for many 
receptors and can act as agonist or antagonists, their biological activities are not simple and often 
associated with many side-effects (Panaccione 2010).  
Dihydrolysergic acid derivatives differ from lysergic acid derivatives in that they lack a 
double bond in their D ring (Figure 5) and thus have vasorelaxant effects, opposite of those 
produced by lysergic acid derivatives. Dihydrolysergic acid derivatives are used in the treatment 
of disorders like dementia (Nicergoline) (Fioravanti & Flicker 2001), Alzheimer’s, and 
Cushing’s disease (Bracco et al. 2004). Patients with frequent, moderate headaches may receive 
a prescription from their provider for a nasal spray or injection called Migranal® a 
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dihydroergotamine (Valeant Pharmaceuticals, QC, Canada); tablets may also be available under 
the name Ergomar® and contain ergotamine (Rosedale Therapeutics, TN, USA) (Reddy 2013).  
Thus, the production of dihydrolysergic acid by a novel fungus may have agricultural and 
pharmaceutical benefits. Dihydrolysergic acid-producing fungi in agriculture may counteract the 
vasoconstrictive effects of natural Epichloë-infected grasses. The development of a more 
efficient process for attaining dihydrolysergic acid, via biosynthesis rather than chemically, can 
be beneficial to the pharmaceutical industry by lowering costs.  
 
2 Study Objectives  
This study will elucidate an unknown step in fumigaclavine synthesis in A. fumigatus. I 
will test the hypothesis that the product of easM is necessary for oxidizing festuclavine to 
fumigaclavine B. One potentially significant outcome of this work would be the production of a 
strain of A. fumigatus that can be used for further studies on the biosynthesis of dihydrolysergic 
acid.   
 
3 Materials and methods  
3.1 Knockout construct preparation 
The easM gene was PCR amplified from A. fumigatus template DNA in a reaction 
primed with easM forward and easM reverse primers (Table 1, Figure 6A). The EasM reaction 
consisted of 25 µL mixture containing: 1 X GoTaq Flexi buffer (Promega, Madison, WI), 1.5 
mM MgCl2, 200 µM each deoxynucleotide triphosphate, 1 µM of each designated primer, and 
2.5 units GoTaq Flexi DNA polymerase (Promega, Madison, WI). The thermocycler program 
that carried out the procedure began with a denaturation step at 95°C for 3 minutes, then 35 
	  10	  
	  
cycles of: 95°C for 30 seconds, 55°C for 30 seconds, and 72°C for 3 minutes, and ending with a 
final extension of 72°C for 5 minutes. The easM fragment is 3,067 bases long, the length of 
which was confirmed by gel electrophoresis (Figure 6). The easM fragment was then ligated into 
plasmid pCR 2.1 to obtain a more concentrated product, and the ligation was transformed into 
Escherichia coli. E. coli colonies were grown on ampicillin-containing medium to select plasmid 
containing colonies. The presence of easM in the plasmid was determined by PCR primed with 
easM forward and easM reverse primers, in the same PCR program as described above. The 
product was then cleaned using a QIAquick column (Qiagen, Gaithersburg, MD).  
To disrupt the easM coding sequence in the plasmid, it was digested with restriction 
enzymes SmaI and ClaI which cut out 1,091 bases located in the middle of the 3,067 base pair 
sequence of easM. The 1,443 base pair hygromycin resistance gene was amplified from template 
pCB1004 in a PCR reaction primed with SmaHygF and ClaHygR using the same thermocycler 
program as described above; recognition sites for SmaI and ClaI were included in the 5’ ends of 
these primers and were used to introduce the hygromycin-resistance fragment into the gap of the 
easM plasmid by ligating the SmaI-ClaI cut hygromycin resistance fragment with the SmaI-ClaI 
cut easM-pCR 2.1 plasmid. The ligation was then transformed into E. coli and the resulting 
colonies were screened for the correct fragment via PCR using easM forward and reverse 
primers to visualize the 3,417 bp fragment of disrupted easM with the hygromicin fragment in 
the middle (Figure 6). As an additional check the fragment was digested again with restriction 
enzymes SmaI, ClaI, EcoRI to visualize that the cut portions corresponded to the predicted sizes. 
The insert of the final plasmid sample was amplified by PCR using easM forward and easM 
reverse primers and Phire Hot Start II polymerase (Thermo-Fisher Scientific, Waltham, MA) in a 
program starting with a 98°C denaturation for 30 seconds, followed by 35 cycles of: 98°C for 15 
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seconds, 65°C for 15 seconds, with a final extension at 72°C for 1 minute. The product was then 
cleaned using QIAquick column (Qiagen, Gaithersburg, MD). 
 
3.2 Fungal transformation and complementation 
The easM-HYG fragment was transformed into A. fumigatus by established methods 
(Coyle and Panaccione 2005) and grown on hygromycin selective medium. Only cells that took 
up the easM-hygromycin knockout construct were able to grow since they had the hygromycin 
resistance gene (Figure 6A).  
To start the culture for transformation, A. fumigatus strain Af293 was grown on malt 
extract agar for approximately three days. Then, 10 mL of malt extract broth was used to create a 
spore suspension which was subsequently inoculated into an additional 20 mL of malt extract 
broth in a 50 mL flask and incubated overnight (approximately 16 hours) on an orbital shaker at 
37°C and 80 rpm. Mycelium was pelleted in a 30-mL Nalgene Oak Ridge tube. Protoplasts were 
prepared by suspending the mycelial pellet in 15 mL of 0.7 M NaCl, 40 mg lysing enzyme 
(Sigma-Aldrich, Saint Louis, MO), and 1 g VinoTaste Pro (Novozymes, Switzerland) and 
allowing the mixture to incubate at 30°C  for two hours. Protoplasts were separated from debris 
via filtration through a Miracloth (Calbiochem, San Diego, CA) funnel. Protoplasts were then 
washed by successively centrifuging (3,000 rpm for 5 min) and resuspending in the following 
solutions: 10 mL 0.7 M NaCl, 5 mL STC (1M sorbitol, 50 mM tris-Cl pH 7.4, 50 mM CaCl2), 
and finally several hundred uL of STC to achieve protoplast concentration of 5x106 protoplasts 
per 100 uL. A solution of two parts 60% polyethylene glycol (PEG) and one part PEG 
amendments (1.8 M KCl, 150 mM CaCl2, 150 mM Tris pH 7.4) was then added to comprise 1/5 
of the volume. Aliquots of 125 µL of protoplast-PEG solution were added to 1.5 mL sterile 
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tubes, along with 10 µL of the easM knockout construct and then incubated on ice for 30 
minutes. An additional 1 mL of PEG solution was added, the mixture was incubated at room 
temperature for 20 minutes and then plated onto Hygromycin (InvivoGen, San Diego, CA) 
selective medium. 
A complementation assay was carried out to demonstrate that the phenotype of the easM 
knockout was due to the disruption at easM and not some other unrelated mutation in the colony. 
The wild-type allele of easM was first amplified from easM forward and easM reverse primers 
with Phire polymerase. The PCR product was cleaned up using Qiagen (Qiagen, Gaithersburg, 
MD) clean up kit. Next, a transformation was performed, as described above with Phleomycin 
(InvivoGen, San Diego, CA) resistance conferred by pBCphelo as the selectable marker onto 
Phleomycin (InvivoGen, San Diego, CA) selective medium.    
 
3.3 PCR analysis of transformants  
DNA preparations from each strain (wild type, easM knockout, and easM complemented) 
were checked via three PCR assays (Figure 6B). A wild-type screen primed with the easM 
forward and easM reverse primers checked for the size of the allele at the easM locus. A three 
prime screen with easNtowardM with YG primers checked for presence of the 3’ portion of 
easM adjacent to the hygromycin resistance gene. A five prime screen based on easDinF with 
HY primers checked for the presence of the 5’ portion of easM adjacent to the hygromycin 
resistance gene.  
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3.4 Alkaloid analysis 
To investigate the types of ergot alkaloids that accumulated in transformants, samples 
were analyzed by high performance liquid chromatography (HPLC) with fluorescence detection 
and liquid chromatography mass spectrometry (LC/MS). 
Six replicate plates of A. fumigatus Af293 wild type, easM knockout, and easM 
complemented were grown on malt extract agar for two weeks. Cultures were extracted by 
removing a ~50 mm2 sample area via the wide end of 1,000-µL pipette tip and suspending it in 
HPLC-grade methanol for an hour, rotating on a carousel. After centrifugation, supernatant (20 
µL) of the extraction was analyzed via reverse phase HPLC. Samples were separated via C18 
column (Phenomenex Prodigy ODS3, 5-µm particle size, Torrence, CA). Ergot alkaloids were 
quantified by comparing peak areas to a standard curve of dihydroergotamine and normalizing to 
number of conidia extracted. Conidia in each extract were counted with the aid of a 
hemocytometer.    
The uncharacterized chemical detected via HPLC eluting from the column at 55.9 
minutes was explored with the aid of a Thermo Fisher LCQ DecaXP LC/MS. Six replicates of A. 
fumigatus Af293 wild type, easM knockout, and easM complemented were grown on malt agar 
plates for two weeks. Spores were suspended in 5 mL HPLC grade methanol and scraped from 
the agar plates with a spreader. Spores were allowed to spin on a carousel for three hours and 
then were centrifuged for ten minutes. Each sample yielded slightly over one mL of extract 
which was subsequently concentrated to 100 µL in a vacuum centrifuge. Of the resulting 
concentrate, 10 µL was then loaded to be analyzed by LC/MS. LC/MS analyses were conducted 
as described by Ryan et al. (2013).   
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3.5 Statistical analysis  
Alkaloid concentrations were analyzed statistically with JMP software (SAS, Cary, NC) 
A Brown–Forsythe test was used to determine equality of group variances with F > 0.05 level. 
With equality of variances determined, an ANOVA was then used to compare quantities of each 
alkaloid among strains, with p<0.05 indicating that chemical concentration varied by strain. This 
indication allowed for the subsequent Turkey-Kramer HSD test, to compare pairs to find 
significantly different means. Results reported in Table 2 display mean alkaloid concentrations ± 
standard error. Letters A, B, or AB within each column indicate the results of the Tukey-Kramer 
test, with same letters showing no difference between strains and different letters indicating a 
statistically significant difference 
 
4 Results 
To test the hypothesis that easM is required for oxidation of festuclavine, easM was 
knocked out by replacing a large part of its coding sequences with a hygromycin resistance gene 
(Figure 6A). A complementation procedure was then carried out to restore the chemical profile 
and confirm easM function.  
 
4.1 easM knockout 
The native copy of easM in A. fumigatus was successfully knocked out through 
homologous recombination with the inactivated easM-HYG construct. Of the 54 transformant 
samples tested by HPLC, 12 showed an accumulation of festuclavine (the intermediate preceding 
the hypothesized EasM step) and loss of fumigaclavine C, the pathway end product (Figure 7). 
An unknown chemical, eluting from the column at 55.9 minutes, also appeared to be affected by 
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the easM knock out (Figure 7). Its identity was investigated via liquid chromatography mass 
spectrometry (LC/MS) in which a molecular ion of m/z 309.3 was detected (Figure 8). This 
molecular ion is consistent with the [M+H]+ for prenylated festuclavine, an alkaloid previously 
detected in A. fumigatus and named 9-deacetoxyfumigaclavine C by Ge et al. (2009).  
Three types of PCR assays showed that the easM-HYG knockout construct was, in fact, 
integrated at the easM locus. The first assay was primed with oligonucleotides flanking the 
intended site of integration (Fig. 6B). The fragment obtained from the easM knockout (KO) was 
larger than that obtained from the wild type (WT) A. fumigatus due to the replacement of a 
portion of the easM coding sequences with the hygromycin resistance genes (Figure 6A). The 
second (5’ screen) and third (3’ screen) assays were each conducted with one primer that flanked 
the 5’ or 3’ end of easM, respectively, and a second primer that annealed to the hygromycin-
resistance gene (Figure 6A). The samples showed predicted size bands for each screen (Figure 
6). This indicated that the wild type sample contained a functional copy of easM as expected, the 
knockout strain contained the easM-HYG construct which was integrated during fungal 
transformation, and that the complemented strain contained both the easM and easM-HYG 
fragments.  
 
4.2 easM complementation 
To demonstrate that phenotype of the easM knockout was due to the integration at easM 
and not any ectopic events, the easM knockout strain was complemented in trans with the wild-
type allele of easM. Complementation resulted in restoration of the wild-type alkaloid profile in 
a qualitative sense (Figure 7). Integration of the complementing easM fragment was confirmed 
via PCR (Figure 6B). The presence of a fragment of wild-type length in the assay primed with 
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easM forward and easM reverse primers indicated the incorporation of the wild-type allele, 
whereas the presence of the longer fragment (typical of the easM knockout strain) indicated that 
the complementing allele had integrated ectopically. Thus the primers amplified the easM wild-
type copy as well as the easM-HYG construct at the previously knocked out easM locus, 
resulting in fragments of 3 kb and 3.4 kb, respectively. Ectopic integration of the complementing 
allele also was supported by the observation of fragments typical of the knockout locus in the 5’ 
flank and 3’ flank PCR assays (Figure 6B).    
 
4.3 Quantitative analysis of ergot alkaloids 
Table 2 displays comparisons of mean alkaloid accumulation in each strain ± standard 
error. Festuclavine accumulated to significantly higher concentrations in the A. fumigatus easM 
knockout than in the A. fumigatus wild type and easM complemented strains (P<0.05).  
 Fumigaclavine B production could be detected in A. fumigatus wild type and 
complemented strains but was eliminated by the easM knock out. Quantities detected in wild 
type and complemented strains do not differ significantly.  
 Fumigaclavine C was detected in the wild type and complemented strains but was lacking 
in the easM knockout strain. The increase in concentration in the complemented strain suggests a 
difference in regulation of the ectopically integrated gene.  
The unknown chemical, hypothesized to be prenylated festuclavine (Figure 8) was 
detected in all three strains. Knock out of easM resulted in a significant increase in concentration 
of this compound. The complemented strain produced an intermediate amount of chemical, thus 
not differing significantly from either wild type or from the knockout strain.  
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5 Discussion 
5.1 Role of EasM in the ergot alkaloid pathway 
The pathway leading to the biosynthesis of lysergic acid is well established, but the 
pathway to dihydrolysergic acid-derived ergot alkaloids has not been elucidated. The objective 
of this study was to genetically manipulate steps in the ergot alkaloid pathway to prepare a strain 
of A. fumigatus suitable for future investigations of the biosynthesis of dihydrolysergic acid 
derived ergot alkaloids. Before exploring the dihydroergot alkaloid origin hypothesis, a 
festuclavine accumulator needed to be obtained. This was done by knocking out the relevant 
gene easM in the A. fumigatus ergot alkaloid pathway. Figure 4 illustrates the ergot alkaloid 
synthesis pathway in A. fumigatus. Genes responsible for the production of enzymes advancing 
each step of the pathway are indicated. However, the gene responsible for oxidizing festuclavine 
into fumigaclavine B had not been characterized. Dr. Panaccione and I hypothesized that the 
enzyme named EasM is responsible for oxidizing festuclavine to produce fumigaclavine B, 
which is then converted into downstream derivatives (Figure 4) based on its capacity to encode a 
P450 monooxygenase and its presence in the ergot alkaloid synthesis gene clusters of 
fumigaclavine producers. PCR and HPLC results along with the statistical analysis of this 
investigation described in the results section provide strong evidence that easM was successfully 
knocked out and complemented. These results indicate that the enzyme encoded by easM is 
necessary for oxidation of festuclavine into fumigaclavine B.    
 
5.2 Differences in alkaloid quantity among wild type, knockout, and complemented strains  
Table 2 shows a clear increase in the concentration of festuclavine and the putative 
prenylated festuclavine in the knockout mutant, this occurs because in the absence of EasM the 
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pathway cannot advance and the fungus accumulates festuclavine (Figure 4) a portion of which 
becomes prenylated by easL. Other data in Table 2 may raise questions regarding the difference 
in alkaloid quantities between the wild type and complemented strains of A. fumigatus. One 
reason for the difference with higher quantities of alkaloid (fumigaclavine C and unknown 
chemical) produced in the complemented strain, may be attributed to the fact that the integration 
of the wild type easM gene into the complemented strain could not be controlled with precision. 
During the transformation procedure relatively high concentrations of the wild type easM gene 
were introduced into the protoplast mixture to facilitate higher probability of complementation. 
Multiple copies of the wild type easM gene could have integrated into the genome. Additionally, 
the integration locus may have affected the quantity of chemical the complemented fungus was 
then able to produce, as some portions of the genome are more regulated than others. Thus the 
quantity of easM genes and their integration loci may be the explanatory factors for the 
difference in alkaloid quantity between the wild type and complemented A. fumigatus strains.  
The transformation approach was chosen because it provided a reasonable strategy for 
analysis of gene function. The knockout construct was prepared in a relatively quick cloning and 
transformation procedure using a selectable marker, followed by a similar procedure for 
complementation. Phenotypes associated with ectopic integration of genes along with selectable 
markers could be reasonably differentiated via PCR and HPLC making this strategy a justifiable 
means for observing gene function. 
The uncharacterized compound that accumulated to higher concentrations in the easM 
knockout strain of A. fumigatus (Figure 7 and 8) is hypothesized to be prenylated festuclavine. 
Rationale for this prediction in that festuclavine accumulates in the easM knockout strain due to 
the absence of a functional easM gene, the accumulated festuclavine may be utilized by an 
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enzyme called EasL. EasL is a prenyl transferase whose typical function is to prenylate 
fumigaclavine A converting it into fumigaclavine C (Unsöld and Li 2006; Robinson and 
Panaccione 2012). Because fumigaclavine A is missing, due to the easM knockout (Figures 4 
and 6) EasL may accept other substrates, in this case festuclavine, prenylating it into the 
compound that eluted at 55.9 minutes (Figure 7) and had a molecular ion of 309.3 Da  (Figure 8). 
The ability of EasL to prenylate a variety of ergot alkaloids has been observed in previous 
studies (Ge et al. 2009; Robinson and Panaccione 2014).   
Fumigaclavines A and B are intermediates between festuclavine and fumigaclavine C 
(Figure 4). Fumigaclavine A was not detected (Figure 7 and Table 2) in any of the strains used in 
this study. Absence of fumigaclavine A may be explained via function of EasL which converts 
fumigaclavine A to fumigaclavine C (Unsöld and Li 2006; Robinson and Panaccione 2012). 
Small quantities of fumigaclavine B were detected because the enzyme EasN had not yet 
converted fumigaclavine B to fumigaclavine A.  
 
5.3 Additional studies and future directions  
A. fumigatus, a fumigaclavine producer, and lysergic acid producers like Claviceps spp. 
and Epichloë spp. differ in their allele for easA within the ergot alkaloid pathway (Coyle et al. 
2010). Epichloë sp. Lp1 CloA typically accepts agroclavine as its substrate and turns it into 
lysergic acid through a series of oxidations and a double bond isomerization (Robinson and 
Panaccione 2014). Expressing Epichloë sp. Lp1 cloA in an A. fumigatus festuclavine 
accumulator may test whether Epichloë sp. Lp1 CloA is able to accept festuclavine and turn it 
into dihydrolysergic acid. Agroclavine and festuclavine differ in their structure only by the 
presence or absence of a double bond in the D ring (Figure 3). One hypothesis is that easA is the 
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only significant difference between dihydrolysergic and lysergic acid producers, with 
downstream enzymes in dihydrolysergic acid producers performing the same functions they do 
in lysergic acid producers.  
Preliminary exploration of expressing an Epichloë cloA gene from an easA A. fumigatus 
promotor did not yield desirable results. The purpose of expressing cloA in an A. fumigatus 
festuclavine-accumulating strain was to test whether Epichloë sp. Lp1 native CloA, which 
typically modifies agroclavine into lysergic acid, would operate similarly in an A. fumigatus 
festuclavine-accumulating strain to produce dihydrolysergic acid. The core of lysergic and 
dihydrolysergic acid only differs by the presence of a double bond (Figure 5); festuclavine also 
possesses this same core (lacking a double bond) which may allow it to serve as a suitable 
substitute for the agroclavine substrate. Thus, CloA should add on functional groups in the two 
subsequent steps to make dihydrolysergic acid instead of the typical lysergic acid product 
(Figure 3). Additionally, evidence exists for permissiveness in substrate recognition in 
downstream enzymes; for example, LPS2 (Figure 3) in Claviceps purpurea has the ability to 
accept dihydrolysergic acid as well as lysergic acid as substrates (Riederer et al. 1996). This 
provides additional evidence that the enzymes of lysergic acid producing fungi have the ability to 
accept dihydrolysergic acid precursors. Epichloë sp. Lp1 cloA was expressed by fusing its coding 
sequences to the A. fumigatus easA promoter and the construct was transformed into the A. 
fumigatus festuclavine-accumulating strain. Conversion of festuclavine to lysergic acid was 
investigated via HPLC. Of the nineteen resulting transformants, integration of DNA was evident 
via PCR, but HPLC results did not indicate production of dihydrolysergic acid derivatives. 
Additionally, a feeding study testing the transformants ability to use exogenously supplied 
agroclavine and elymoclavine as substrates indicated that CloA was not utilizing the substrates 
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for conversion to downstream products. There are many reasons why the expression of cloA may 
not have worked: damaged DNA, integration of construct at a non-ideal site in the genome, lack 
of affinity for festuclavine (a dihydrolysergic acid precursor) as a suitable substrate, or perhaps a 
combination of native alleles (easA and cloA) are needed to make festuclavine work as a 
substrate for conversion to lysergic derivatives. Several fungi including A. fumigatus and 
Epichloë sp. have easA genes but their alleles differ. This may mean that the easA and cloA 
alleles from Epichloë may need to be transformed into A. fumigatus, as opposed to utilizing cloA 
from Epichloë sp. Lp1 and letting A. fumigatus utilize its own easA. Additional attempts have 
been made in utilizing easA and cloA from the same fungus, namely Epichloë but transformants 
did not result in desirable HPLC profiles. I suggest that future studies attempt to express other 
alleles of easA and cloA in the A. fumigatus festuclavine accumulator in an attempt to convert 
festuclavine to dihydrolysergic acid.  
 
5.4 Conclusion 
The ergot alkaloid synthesis cluster gene easM encodes a P450 monooxygenase that is 
necessary for oxidizing festuclavine into fumigaclavine B. Elucidating easM function is 
important as it adds to our knowledge of the ergot alkaloid pathway. Because easM had been 
sequenced but not yet characterized, this project provides evidence for easM’s function which 
had previously not been documented. Moreover, the engineering of a festuclavine accumulating 
A. fumigatus strain is instrumental in the next phase of research for the biosynthesis of 
dihydrolysergic acid. Dihydrolysergic acid derivatives are vasorelaxant and are the active 
compounds in drugs that help treat disorders like dementia, and Alzheimer’s. Agricultural  
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applications for dihydroergot alkaloid producers which may counteract natural lysergic acid 
producing grass endophytes also exist.   
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Figures and Tables      
	  
Figure 1: Divergence of the ergot alkaloid pathway at the chanoclavine-I aldehyde branch point. 
Note: Asexual Epichloë spp. were previously called Neotyphodium spp. The figure was modified 
from Panaccione et al. (2012). 
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Figure 2: Ergot alkaloid synthesis gene cluster of A. fumigatus (A) redrawn from Coyle and 
Panaccione (2005). Epichloë sp. Lp1 ergot alkaloid synthesis cluster (B) redrawn from Schardl et 
al. (2013). Compressed regions are designated with hash marks to allow for concise presentation. 
Arrows indicate direction of transcription. Functions have been assigned for all genes other than 
easM and easK.   
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Figure 3: Ergot alkaloid pathway reproduced from Robinson & Panaccione (2014).  
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Figure 4: Ergot alkaloid pathway in A. fumigatus, showing genes (above corresponding arrows) 
responsible for each step (Panaccione 2010).  
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Figure 5: Lysergic acid and dihydrolysergic acid. The chemicals are the same except 
dihydrolysergic acid lacks a double bond in one of its rings.  
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Figure 6: (A) Schematic representation of easM locus in A. fumigatus before and after gene 
knock out. (B) PCR products of A. fumigatus isolate Af293 wild type, easM knockout, and easM 
complemented strains. Wild type screen is checking for the easM fragment. Three prime screen 
was primed with primers that anneal beyond the 3’ end of easM and the middle of the 
hygromycin resistance gene. Five prime screen was primed with oligonucleotides that anneal 
before the 5’ end of easM and in the middle of the hygromycin resistance gene.   
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Figure 7: High performance liquid chromatography (HPLC) results illustrating ergot alkaloid 
accumulation in wild type, easM knock out, and complemented A. fumigatus strains. Data were 
collected with a fluorescence detector (excitation 272 nm/emission 372 nm). Festuclavine eluted 
from the column at 41.9 minutes, fumigaclavine C eluted at 59 minutes, and a partially 
characterized compound (putative prenylated festuclavine; designated with an asterisk) eluted at 
55.9 minutes. 
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Figure 8: Mass spectrum and predicted structure of chemical accumulating to higher 
concentrations in the A. fumigatus easM knockout strain.  
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Table 1 PCR primers used in this study and their products.  
Primer 
combination 
Primer sequence 5’ à 3’ Product Amplicon 
length (bp) 
easMF +  
easMR 
GCCATTCCTCCACTCTTCAG + 
CCAAAGAACATTCCCAGCTC 
 
 
easM 
 
3,067 
easNtowardM+ 
YG 
GACTGCCAGTATCATCTACC + 
CGTTGCAAGACCTGCCTGAA 
3’ flank of 
integrated 
ko construct 
 
2,057 
easDinF + 
HY 
ACTGCGCTACAGTCGATGTAAC + 
GGATGCCTCCGCTCGAAGTA 
5’ flank of 
integrated 
ko construct 
 
2,916 
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Table 2 Mean alkaloid concentration (mean amol/spore ± standard error; n = 6) in A. fumigatus 
wild type, easM knockout, and easM complemented strains. Within each column, designation 
with different letters indicates significant difference (α=0.05) in a Tukey-Kramer HSD test (or 
one-way ANOVA, when alkaloid detected in two strains). 
Strain Festuclavine  Fumigaclavine B Fumigaclavine C Unknownª 
A. fumigatus Af293 
wild type  
6.30 ± 4.92 A 0.58 ± 0.09 A 8.83 ± 1.37 A 1.19 ± 0.90 A 
A. fumigatus Af293 
easM knockout 
33.59 ± 9.19 B n.d.b n.d. 8.39 ± 3.14 B 
A. fumigatus Af293 
easM complemented 
13.91 ± 6.38 A 0.35 ± 0.05 A 23.12 ±  3.90 B 4.64 ± 3.72 AB 
 a putative prenylated festuclavine  
b not detected; limit of detection = 0.01 amol/spore.  
